Document Detail

Cardiac autonomic modulation during methadone therapy among heroin users: A pilot study.
MedLine Citation:
PMID:  22285679     Owner:  NLM     Status:  Publisher    
BACKGROUND: Methadone therapy benefits heroin users in both the medical and psychosocial dimensions. However, both heroin and methadone have cardiac toxicity. Only limited information is available describing the changes in cardiac autonomic function of heroin users and effects of methadone therapy. We conduct the current study to explore the cardiac vagal function in heroin users as well as the impact of lapse and methadone therapy. METHODS: 80 heroin users from a methadone therapy clinic were distributed into 31 compliant and 49 incompliant patients according to whether they lapsed into heroin use within 10days. 40 healthy control subjects were recruited from the community. Participants underwent electrocardiographic recordings and the heroin users were further investigated before and after methadone therapy. Spectral analysis of heart rate variability (HRV) was computed for cardiac parasympathetic modulation (high-frequency power, HF) and cardiac sympathetic modulation (normalized low-frequency power, LF%). RESULTS: The baseline HRV parameters found lower HF values for heroin users and lower RR interval values for patients with a recent lapse compared with the healthy control subjects. After 1h of methadone administration, heroin users who had lapsed showed a significant increase in HF but the heroin users who had not lapsed did not. CONCLUSION: Our findings suggest that heroin users show decreased cardiac vagal activity and that methadone therapy immediately facilitates vagal regulation in patients with a recent lapse. The differential patterns of autonomic alteration under methadone between those with and without lapse might offer an objective measure of lapse.
Li-Ren Chang; Yu-Hsuan Lin; Terry B J Kuo; Yen-Cheng Ho; Shiuan-Horn Chen; Hung-Chieh Wu Chang; Chih-Min Liu; Cheryl C H Yang
Related Documents :
8749269 - Effects of ace inhibitors on mortality when started in the early phase of myocardial in...
18439049 - Use of secondary prevention drug therapy in patients with acute coronary syndrome after...
12447159 - Special clinical considerations of beta-blocker treatment.
22622649 - Levosimendan versus milrinone in neonates and infants after corrective open-heart surge...
21705999 - Optimal role of rest and stress echocardiography in cardiac resynchronization therapy.
22511509 - Successful high-risk percutaneous coronary intervention with the use of minimal extraco...
1800299 - Left ventricular mass in normal indian population.
24444479 - Low socioeconomic status increases short-term mortality of acute myocardial infarction ...
18704819 - Hemodialysis-induced left ventricular dysfunction is associated with an increase in ven...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-21
Journal Detail:
Title:  Progress in neuro-psychopharmacology & biological psychiatry     Volume:  -     ISSN:  1878-4216     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8211617     Medline TA:  Prog Neuropsychopharmacol Biol Psychiatry     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Department of Psychiatry, National Taiwan University Hospital, Yun-Lin Branch, Taipei, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Dual energy X-ray absorptimetry: fundamentals, methodology, and clinical applications.
Next Document:  Adsorption of Ni(II) ions on colloidal hybrid organic-inorganic silica composites.